Request For Applications: Incentive Grants for New Investigators in Gambling Research
Institute for Research on Pathological Gambling and Related Disorders
All Regions
11/03/2008
$50,000

Request For Applications: Incentive Grants for New Investigators in Gambling Research

APPLICATION DEADLINE: NOVEMBER 3, 2008
The Institute for Research on Pathological Gambling and Related
Disorders is pleased to announce the availability of Incentive
Grants of up to $25,000 per year for two years. The purpose of this
award is to encourage new investigators to enter the field of gambling
studies by providing seed funds for research on gambling and gamblingrelated
problems. Investigators who have a terminal degree (e.g., Ph.D.,
M.D., M.P.H., J.D.) and who have no more than 10 years of post-graduate
research training experience at the time of the application receipt date
(November 3, 2008) are eligible to apply for an Incentive Grant.

ELIGIBLE APPLICANTS
To be eligible for an Incentive Grant,
applicants must have a terminal degree
(e.g., Ph.D., M.D., M.P.H., J.D.) and no
more than ten years of post-graduate
research training experience at the time of
the application receipt date (November 3,
2008). This grant category is intended to
support new investigators (e.g., postdoctoral
fellows, assistant professors, or
equivalent). Students and investigators
with rank higher than assistant professor
are not eligible to apply.
Applicants are eligible for a maximum of
two Incentive Grants for New Investigators.
Previous awardees at the post-doctoral or
assistant professor level are encouraged to
apply for a second award. However, awards
cannot overlap in time. Applicants must
not submit more than one application per
cycle.
PRIORITY AREAS
The Institute requests proposals for
investigator-initiated research that will
consider the influence of cognitive,
personality, emotional, neurobiological,
economic, and psychosocial influences
associated with the etiology, maintenance
of and recovery from gambling disorders.
While a broad range of topics will receive
consideration, the Institute is especially
interested in the following areas:
• Treatment outcome
• Self-guided recovery and brief
interventions
• Determinants of disordered
gambling
• Resilient and vulnerable population
segments
• Comorbidity
• Prevention and responsible gaming
• Neurobiology of gambling disorders
• Social and economic impact

The Division on Addictions
Cambridge Health Alliance
an affiliate of Harvard Medical School
Station Landing
101 Station Landing, 2nd Floor
Medford, MA 02155
Phone: (781) 306-8600

Email: info@divisiononaddictions.org

Health Services Researcher, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Lawyer, New Investigator, New Researcher, Physician Researcher, Policy Analyst, Psychiatrist , Psychologist, Public Health Expert, Social Scientist, Social Worker, Young Investigator, Young Scientist
American Federation for Aging Research Research Grants
American Federation for Aging Research
All Regions
12/16/2008
$75,000

The 2009 AFAR Research Grants

The Program
The major goal of this program is to assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research. AFAR supports research projects concerned with understanding the basic mechanisms of aging. Projects investigating age-related diseases are also supported, especially if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders are also encouraged, as long as these include connections to fundamental problems in the biology of aging. Projects that deal strictly with clinical problems such as the diagnosis and treatment of disease, health outcomes, or the social context of aging are not eligible.

Examples of promising areas of research include:
Aging and immune function
Genetic Control of longevity
Neurobiology and neuropathology of aging*
Invertebrate or vertebrate animal models
Cardiovascular aging
Aging and cellular stress resistance
Metabolic and endocrine changes
Age-related changes in cell proliferation
Caloric restriction and aging
DNA repair and control of gene expression
Biology of the menopause
Aging and apoptosis
Biodemographic analysis of aging
Comparative gerontology
Evolutionary biological aspects of the biology of aging
*Applicants proposing a project in Alzheimer's Disease research, should apply for the Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease. (This program is currently under review for renewal in 2009.)

It is anticipated that approximately 15 grants of up to $75,000 each will be awarded in 2009. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Funds may not be requested for overhead or indirect costs. Funding will begin July 1, 2009.

Recipients of this award are expected to attend the AFAR Grantee Conference. The purpose of the meeting is to promote scientific and personal exchanges among recent AFAR grantees and experts in aging research.

Eligibility

The applicant must be an independent investigator with assigned independent space and must be within the first four years of a junior faculty appointment (instructor, assistant professor or equivalent) by July 1, 2009.

The AFAR Research Grant Program does not provide support for:
Postdoctoral fellows in the laboratory of a senior investigator
Investigators who have already received major extramural funding for research on aging (such as an R01 grant)
Senior faculty, i.e. at the rank of Associate Professor level or higher
Former AFAR Research Grant recipients
NIH Intramural program employees
Applicants for the 2009 Glenn/AFAR Breakthrough in Gerontology (BIG) award
Application Guidelines

Four criteria are used to determine the merit of an application:

Qualifications of the applicant;
Quality of the proposed research;
Excellence of the research environment;
Likelihood that the project will advance the applicant's career in aging research.
If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.

Application Procedures

All candidates must submit applications endorsed by their institution (only not-for-profit settings in the United States.) The deadline for receipt of all applications and supporting materials is December 16, 2008 at 5:00 p.m. EST. Please refer to the AFAR instruction sheet and application for complete application procedures. Incomplete applications cannot be considered.

Applications are reviewed in two stages: The initial screening takes place in mid-April, after which candidates are advised of the status of their applications via email. A final decision about grant awards is made in early June. The award start date is July 1, 2009.

AFAR can provide critiques only for those applications that are reviewed, at the second stage, by their Review Committee.

Reporting Requirements

Investigators will be required to submit a brief narrative report on the progress of their research five months after the start date of the award. Final narrative and financial reports are required within three months following the end date of the award. 

American Federation for Aging Research (AFAR) | 55 West 39th Street, 16th Floor | New York, NY 10018
Phone: (212) 703-9977 | Toll-free: (888) 582-2327 | Fax: (212) 997-0330
E-mail: grants@afar.org or info@afar.org

Biostatiscian, Cell Biologist, Geriatrician, Gerontologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Molecular Biologist , Physician Researcher, Scientist, Young Investigator, Young Scientist, Cardiologist, Endocrinologist, Immunologist, Internist, Neuroscientist, Nutritionist, Physiologist
Prize4Life Biomarker Prize - Second Track--Amyotrophic Lateral Sclerosis
Prize4Life
All Regions
11/06/2008
$1,000,000
Prize4Life announced its 2-year $1 million ALS/MND Biomarker Challenge on November 6, 2006.

The Prize4Life Biomarker Prize is divided into two tracks - theoretical findings and real outcomes.

The first track was a call for scientists and researchers from all backgrounds to submit theoretical papers on how they would develop a biomarker for ALS. In May 2007, Prize4Life awarded $15,000 for each of the five best ideas submitted . This track is now closed for submissions.

The second track, currently running, involves identifying an actual ALS biomarker. Anyone can submit a solution to the second track at any time, regardless of whether they participated in the first track.

A prize of up to $1,000,000 will be awarded in track two for the first validated ALS biomarker submitted that meets the desired requirements. Those submitting a solution must provide statistically significant results as proof of the validity of the solution. This challenge will end in November 2008 if a winning solution is not received so send in your solution now!!

A biomarker is a distinctive biological or biologically derived indicator that can mark the presence and/or progression of a disease. A biomarker can take the form of a chemical marker, a mechanical device that measures relevant physiological changes, or combination of the two. Currently, there are no known biomarkers for ALS for either diagnosing or measuring the progression of the disease.

Interested scientists and researchers should REGISTER with Prize4Life.

INNOCENTIVE 4470259
ALS Biomarker
POSTED: NOV 06, 2006
DEADLINE: NOV 06, 2008
$1,000,000 USD
Biochemist, Cell Biologist, Molecular Biologist , Neurologist, Neuroscientist, Physician Researcher
Research Grants-Huntington's Disease
Hereditary Disease Foundation
All Regions
10/15/2008
$50,000
Research grants

The focus of the Hereditary Disease Foundation is on Huntington's disease. Support will be for research projects that will contribute to identifying and understanding the basic defect in Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons.

Anyone accepting funding from the Hereditary Disease Foundation must agree to abide by the following policy: Propagatable materials (including monoclonal antibodies and recombinant DNAs) should be freely available to other investigators following publication. The Foundation's position is that there be no restrictions or proprietary rights in materials produced with our support.

Deadlines for applications are February 15, June 15 and October 15. Applications will be reviewed in May, September and January. To obtain an application, please submit a letter of intent no more than one page long. It may be submitted at any time to following address,

Hereditary Disease Foundation
Attn: Carl D. Johnson, PhD
3960 Broadway, 6th Floor
New York, NY 10032
USA

The maximum award for research grants is $50,000. Grants are usually for one year with a possibility of renewal. Grants are considered seed money. If the project shows promise, it is hoped that other institutions will fund it thereafter. The Foundation does not generally include the salary of the principle investigator. Indirect costs are not allowed, but fringe benefits are considered part of personnel costs and are allowed.

Grant applications should be submitted by email and five hard copies. Supplemental material and reprints should be submitted with a file type of PDF(.pdf).

Applicants are notified of funding decisions by letter only.

To apply:

· Submit a letter of intent: There is no deadline – submit anytime, electronically using the form on the Foundation’s website:
http://www.hdfoundation.org/funding/intent.php.

The letter of intent should include:

o Contact information

o A summary of your proposed research project – 500 words or less

· Letter of Intent Review: Letters of intent are reviewed by a triage group. Turn-around is usually less than two weeks and the primary consideration is relevance to finding treatments and cures for Huntington’s disease. If a proposal is accepted, an application form for a full proposal is sent to the applicant by email. Applicants are encouraged to interact by email or phone with Carl Johnson, Ph.D., the Executive Director for Science, while preparing their application

Applications require:

· Administrative contact: Name, title, email address, phone & fax numbers and mailing address of the institutional representative who will manage the project. The application must be approved and signed by the institution.

· Project summary: Not to exceed 200 words.

· Budget (for Grants only): Grant funding is limited to $50,000. Except in unusual circumstances, salary support is not provided for the Principal Investigator. The Foundation does not provide funds for indirect costs or overhead. Postdoctoral Fellowship salaries are determined by the Foundation, based on number of years after receipt of a doctoral degree. Postdoctoral Fellowship Awards include $8,000 for supplies.

· Other current and pending support: Please provide a complete list (NIH format) indicating aims of each project and potential overlap with the current proposal.

· Biographical sketch: Attach a two-page biographical sketch (NIH format) for the Principal Investigator and other professional personnel. Include training, experience, recent publications and patent filings. Any supplemental materials, manuscripts or papers should be submitted electronically in PDF format.

· Protection of Human Subjects: Any study using human subjects must be approved by the Institutional Review Board (IRB) of the applicant institution. Please attach the completed “Protection of Human Subjects Assurance/Certification/Declaration” form.

· Protection of Animal Subjects: The transportation, care, and use of animals must be in accordance with the Animal Welfare Act (7 U.S.C. 2131 et. seq.) and other applicable Federal laws, guidelines, and policies.

· Study Proposal: Not to exceed 10 pages, including references. There is no need for an extensive, NIH style, introduction, but be sure to include a description of critical details of the proposed plan as well as documentation of research experience. Particular attention should be paid to the aims and anticipated outcomes of the study and on how they will help discover or develop treatments for Huntington’s disease.

Application Review:

Applications are reviewed by the Scientific Advisory Board of the Hereditary Disease Foundation. The SAB meets three times each year: in January, May and October. Applications received at least six weeks prior to the meeting are considered. Applicants will receive written notification of the funding decision shortly after the review meeting.

Award Payment:

If the application is approved for funding, payment will be made in two equal installments. Awardees must arrange, via email or in writing, activation of the Award. The first payment is sent immediately; the second will be made six months later, upon receipt of a progress report via email. A final report including a financial statement is also required.

Please submit completed applications both by email and five hard copies to:

Hereditary Disease Foundation
Attn: Carl D. Johnson, Ph.D.
Executive Director for Science
3960 Broadway, 6th Floor
New York, NY 10032
Cell Biologist, Molecular Biologist , Neurologist, Neuroscientist, Physician Researcher
John J. Wasmuth Postdoctoral Fellowships
Hereditary Disease Foundation
All Regions
10/15/2008
$64,000
John J. Wasmuth Postdoctoral Fellowships

The John J. Wasmuth postdoctoral fellowships are named in honor of the late John Jacob Wasmuth who was an essential member of the Huntington's Disease Collaborative Research Group and a long-term and valued member of our Scientific Advisory Board. John was a superb mentor. It is our hope that those granted fellowships bearing his name will seek the same level of creativity, imagination, rigor and esprit de corps that characterized John.

The Hereditary Disease Foundation offers support for research projects that will contribute to identifying and understanding the basic defect of Huntington's disease. Areas of interest include trinucleotide expansions, animal models, gene therapy, neurobiology and development of the basal ganglia, cell survival and death, and intercellular signaling in striatal neurons.

Anyone accepting funding from the Hereditary Disease Foundation must agree to abide by the following policy: Propagatable materials (including monoclonal antibodies and recombinant DNAs) should be freely available to other investigators following publication. The Foundation's position is that there be no restrictions or proprietary rights in materials produced with our support.

Deadlines for applications are February 15, June 15 and October 15. Applications will be reviewed in May, September and January. All John Wasmuth Fellowships are automatically considered in January of every year for the Milton Wexler Fellowship award.

To obtain an application, please submit a letter of intent no more than one page long. It may be submitted at any time to the following address,

Hereditary Disease Foundation
Attn: Carl D. Johnson, PhD
3960 Broadway, 6th Floor
New York, NY 10032
USA

John J. Wasmuth Postdoctoral Fellowship awards are based on the following scale which includes all university fringe benefits plus $8,000 for supplies:

0 years since Ph.D. = Stipend of $40,500

1 year since Ph.D. = Stipend of $43,000

2 years since Ph.D. = Stipend of $46,000

3 years since Ph.D. = Stipend of $48,200

4 years since Ph.D. = Stipend of $50,200

5 years since Ph.D. = Stipend of $52,400

6 years since Ph.D. = Stipend of $54,500

7 years since Ph.D. = Stipend of $56,000
Indirect costs are not allowed, but fringe benefits are considered part of personnel costs and are permitted.

Funded fellowships will be renewed for a second year, subject to satisfactory progress reports.

The completed application packet will consist of the application, the curriculum vitae of the applicant and the applicant’s research sponsor, a letter of support from the sponsor, and two letters of recommendation from two others familiar with the applicant, one of whom is normally the applicant’s PhD. sponsor.

Note: Completed applications should be submitted by email and five (5) hardcopies. Supplemental material and reprints should be submitted with a file type of PDF (.pdf).

Applicants are notified of funding decisions by letter only.

A list of previous Postdoctoral Fellows is available on request.

Hereditary Disease Foundation
3960 Broadway, 6th Floor
New York, NY 10032
Voice: (212) 928-2121
Fax: (212) 928-2172

http://www.hdfoundation.org

Please feel free to contact the Hereditary Disease Foundation by phone at
1 (212) 928-2121 with questions or comments regarding the application process
Cell Biologist, Molecular Biologist , Neurologist, Neuroscientist, Scientist, Physician Researcher
Institute for Neuroacanthocytosis Research Grants
Institute for Neuroacanthocytosis
All Regions
10/15/2008
$50,000

Institute for Neuroacanthocytosis Research Grants

We encourage applications for research grants for investigations into the genetics, diagnostics and epidemiology of the NA syndromes as well as the pathophysiology and the related red blood cell abnormalities.
Neuroacanthocytosis syndromes are a group of rare diseases, characterised by misshaped erythrocytes and progressive neurodegeneration, causing movement disorders and neuropsychiatric symptoms.

The rarity and wide geographical spread of the NA diseases have contributed to a number of different researchers principally in Europe and Japan pursuing specific studies of the elements of the NA phenotypes including descriptive history of the development of the disease, the abnormalities of the erthrocytes and the function of the VPS 13A protein that is absent in chorea-acanthocytosis.

Since acanthocytosis is part of the NA syndromes clinical manifestations, the study of acanthocytes may offer the possibility to progress in the disease’ knowledge, to identify new cell signalling pathways towards either membrane proteins or transport systems.

Our Objectives for Research

To pursue the fundamental physiological questions raised by NA including the:

role of the proteins affected by the mutated genes in each disease as well as their molecular and cellular function

cause and significance of the spiky red blood cell membranes that are a defining characteristic of the diseases

pathway that leads to neuronal apoptosis in each of the diseases

To promote wide collaboration in the clinical study of the diseases. Because no country has more than an estimated 100 cases of NA and most countries in the world have fewer than 10 cases, it is vital that case histories of patients from around the world be available to those studying the clinical aspects of the diseases.

To develop the tools and the skill of neurologists to diagnose and, in the future, to treat the diseases.

To collaborate effectively with research into other similar conditions especially Huntington’s disease.

To encourage new, promising projects with seed money and assist in approaching larger grantors.

Our Values

Our funding seeks to:

Promote basic, curiosity-driven, investigator–led research that relates to the phenotypes of the NA diseases.

Bring together the wide research community around the world including haematology, cell biology, neuroscience and neuropsychiatry.

Encourage the wide dissemination of and free access to the research we support. We will seek to support unrestricted access and the public benefit wherever possible by requiring electronic copies of any research papers that have been accepted for publication in a peer-reviewed journal and are supported by the Advocacy to be deposited into PubMed Central (PMC) to be made freely available as soon as possible and in any event within six months of the journal publisher’s official date of final publication.

Do every thing possible to have strong communication with researchers receiving grants to assure that funds are used for the intended purpose.

Promote good communications between those working on NA research and others concerned with other diseases of the basal ganglia.

 

Cell Biologist, Hematologist, Neurologist, Neuroscientist
Children's Eye Foundation Grants
Children's Eye Foundation
All Regions
12/31/2008
$0
The Children's Eye Foundation is committed to providing funding to early career investigators for innovative projects in vision science that focus on the infant and child's visual system and its disorders, as well as strabismus in adults. Current priority funding areas include neurobiology, molecular biology, genetics and biotechnology.

During its 36+ years the Foundation has granted over $1 million in support of research and education to advance the understanding of, and care for, children with eye and visual system disorders and adults with strabismus. If you would like to apply for a Children's Eye Foundation Grant, please contact:

Richard W. Hertle, M.D.
Chief of Ophthalmology
Children's Hospital of Pittsburgh
Director of Pediatric Ophthalmology & Strabismus UPMC Eye Center, Eye & Ear Institute Professor of Ophthalmology and Bioengineering University of Pittsburgh School
of Medicine.
Phone 412.692.8940
Fax 412.692.7220



Here are three projects currently being funded in part by the Foundation.

MAGNETOENCEPHALOGRAPHY (MEG) AND AMBLYOPIA TREATMENT

CELLULAR RELEASE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN RESPONSE TO INSULIN-LIKE GROWTH FACTOR (IGF-1) STIMULATION

VISUAL DEVELOPMENT IN PREMATURE INFANTS
Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Young Investigator, Young Scientist